Author Manuscript Published OnlineFirst on November 29, 2019; DOI: 10.1158/0008-5472.CAN-19-2782 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Argonautes in extracellular vesicles: artifact or selected cargo? Alissa M. Weaver1,2, # and James G. Patton1,3,4 1. Department of Cell and Developmental Biology, Vanderbilt University School of Medicine 2. Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center 3. Department of Biological Sciences, Vanderbilt University 4. Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center 5. # Correspondence to Alissa M. Weaver, 771 Preston Research Building, Vanderbilt University School of Medicine, Nashville, TN 37212 USA. Email:
[email protected] Phone: 1-615-936-3529 Running Title: Argonautes as EV cargoes Abbreviations: Ago: Argonaute, EV: extracellular vesicle, miRNA: microRNA, RBP: RNA- binding protein, RISC: RNA-induced silencing complex, TRBP: transactivation response RNA- binding protein, WAGO: worm Argonaute Conflict of Interest Declaration: The authors have no financial conflicts of interest. We have published manuscripts in the area discussed in this “Controversy and Consensus”, which we have referenced. 1 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on November 29, 2019; DOI: 10.1158/0008-5472.CAN-19-2782 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Argonaute-2 (Ago2) is a key component of the RNA-induced silencing complex (RISC) that mediates downregulation of mRNA by microRNAs. Its presence in extracellular vesicles (EVs) has been postulated to be important for the activity of EV-carried miRNA in modulating gene expression in recipient cells.